Cargando…

PB2096: A PHASE 1B/2 STUDY OF GB5121, A NOVEL, HIGHLY SELECTIVE, POTENT, AND CNS-PENETRANT BTK INHIBITOR FOR RELAPSED/REFRACTORY PRIMARY/SECONDARY CNS LYMPHOMA AND PRIMARY VITREORETINAL LYMPHOMA

Detalles Bibliográficos
Autores principales: Soussain, C., Grommes, C., Ward, R., Peterson, C., Cravets, M., Mathias, A., Sosa, J., Kirby, B., Ding, Z., Yusuf, I., Rose, M., Steinberg, M., Tun, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428960/
http://dx.doi.org/10.1097/01.HS9.0000851216.47783.78